Venus Remedies receives Ukrainian GMP approval for Its Carbapenem, Oncology parenteral facilities
The company expects this approval in Baddi to pave the way for GMP certifications from European Medicines Agency and other PIC/S member nations
The company expects this approval in Baddi to pave the way for GMP certifications from European Medicines Agency and other PIC/S member nations
Brexit had a negative impact on NHS staff shortages and worsened the workforce crisis
Company intends to increase sales in the UK to approximately 2 million Euros by focusing on seven molecules which are already registered in the country
SVB Financial Group and its subsidiaries were involved in over $1.4 billion in total venture financing raised from 2010 to 2022 for drug development
Department of Biotechnology is going to play an important part in the integrated holistic healthcare approach against elimination of Tuberculosis
With the combination of oral solid, inhalation, dermatology, high potent and oral contraceptive products, this is an important facility of the company
The product will be manufactured at the plant of Bell, Sons & Co. (Druggists) Ltd. located at Gifford House, Slaidburn Crescent, Southport, UK
Surana is a chartered accountant with an all-India rank.
EZHARMIA is the fifth innovative oncology medicine to be launched in Japan by Daiichi Sankyo in the past three years
Aster DM Healthcare and Faruk Medical City will jointly provide training and academic support to medical and paramedical staff
Subscribe To Our Newsletter & Stay Updated